M Ventures is a venture capital firm that focuses on making direct investments in early-stage companies, particularly in the biotechnology and technology sectors. Headquartered in Amsterdam, the firm targets innovative companies that address significant challenges in healthcare, life sciences, electronics, and sustainability. With a commitment to supporting visionary entrepreneurs, M Ventures seeks to advance transformative ideas that enhance drug development, empower scientific research, and improve technological solutions for information management. The firm plays an active role in its portfolio companies, aiming to foster innovation that can lead to substantial impacts in their respective fields.
Vice President and Head of Performance Materials Fund
Sarah Luppino
Associate
Pia Michel
Analyst
Michael Palank
General Partner
Christian Patze
Associate, Performance Materials
Jennifer Randle
COO
Javier Rodriguez
CFO
Sebastian Schoefer
Senior Associate
Christian Uhrich
Investment Director, Biotechnology team
Christian Uhrich
Investment Director
Bram Vanparys
Director
Ilja Aizenberg
Principal, Technology
Cheryl Zimberlin
Associate
Henry Zubaida
Analyst
Tobias Egle@m
Associate
Daniel Franke
Associate
399 past transactions
Cosmic Robotics
Pre Seed Round in 2025
Autonomous construction on Earth and beyond.
Corvic AI
Seed Round in 2025
Corvic AI is pioneering a new era of Data-Centric AI Cognitive Infrastructure by transforming raw enterprise data into AI-ready intelligence.
Conifer
Seed Round in 2025
Conifer builds compact and modular powertrains to power everything that moves.
Chef Robotics
Series A in 2025
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.
MemryX
Series B in 2025
MemryX Inc. is a fabless semiconductor company based in Ann Arbor, Michigan, specializing in in-memory computing solutions that enhance performance for data-intensive applications. Founded in 2018, the company develops memory processing units that leverage proprietary compute-at-memory technology and dataflow architecture to address the limitations of traditional CPU and GPU systems. These chips are designed for edge AI processing, offering high performance, accuracy, and energy efficiency for sectors such as transportation, IoT, and various industrial and consumer applications. MemryX aims to eliminate data movement bottlenecks by integrating memory and processing capabilities, thereby optimizing efficiency and flexibility for its clients. The company is supported by notable investors, including HarbourVest and the Arm IoT Fund, and has additional offices in Bangalore, India, as well as Taipei and Hsinchu, Taiwan.
TRIMTECH Therapeutics
Seed Round in 2025
TRIMTECH Therapeutics is a biotech organization that treats neurodegenerative illnesses by using targeted protein degradation (TPD).
Era Finance
Seed Round in 2025
Era is a financial management platform driven by AI that makes asset management more accessible.
Coval
Seed Round in 2025
Coval is a simulation and evaluation platform for AI agents, enabling engineers to deploy reliable assistants across chat and modalities.
NovoLINC
Seed Round in 2025
NovoLINC is a pioneering startup that provides thermal interface solutions. It develops a distinctive system of nanostructured materials and a proprietary manufacturing process with the objective of transforming thermal management.
Abselion
Series A in 2024
Abselion specializes in the development of biological sensors aimed at the rapid and cost-effective detection of various biological substances, including proteins, DNA, and small molecules. The company's innovative diagnostic analyzers and kits simplify the analysis of these biomolecules, making them valuable tools for pharmaceutical research and manufacturing. By enabling researchers to conduct sensitive, rapid, and near real-time medical diagnoses, Abselion enhances the understanding of biomolecular interactions, particularly in protein interaction analysis. This focus on efficiency and accuracy positions Abselion as a key player in the field of biosensing technology.
StoreCash
Seed Round in 2024
StoreCash is a mobile payment service that facilitates transactions through QR codes at more than 200,000 retail locations. The platform is specifically designed to cater to unbanked teenagers, allowing them to manage and make payments instantly from their mobile devices without the necessity of a bank account. Users can also earn cash back on their purchases, further enhancing the appeal of the service. By providing a straightforward and efficient payment solution, StoreCash aims to simplify the payment process for individuals who might otherwise face barriers in traditional banking systems.
IonKraft
Seed Round in 2024
IonKraft can provide better performance at a lower cost while maintaining recyclability, they also promote material reduction and reuse and are commercializing the technology with funding from the German Federal Ministry for Economic Affairs and Energy (BMWi).
Kivu Bioscience
Series A in 2024
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets.
Fin
Seed Round in 2024
Fin is a transportation company that provides zero-emission, sustainable parcel delivery, and logistics services for e-commerce brands. Its deliveries and warehousing services serve e-commerce, retail, and logistics industries.
Enara Bio
Series B in 2024
Enara Bio is a biotechnology company based in Oxford, United Kingdom, focused on developing vaccines and immunotherapies for cancer treatment and prevention. Founded in 2016, the company specializes in identifying and utilizing novel antigens derived from endogenous retroviral DNA sequences to create therapeutic cancer vaccines. Enara Bio's technology platform enables the exploration of dark antigens, assessing their tumor specificity and immunogenic potential, which is crucial for effective cancer therapies. The company's innovative approach targets the interaction between T-cells and cancer cells, aiming to create targeted immunotherapies that can benefit a broad patient population.
PictorLabs
Series B in 2024
PictorLabs is a digital pathology company advancing AI-powered virtual staining technology to revolutionize histopathology and accelerate clinical research with the goal of improving patient outcomes. Led by a team with deep expertise in bioengineering, artificial intelligence and health-tech product development, the Company is reimagining the age old practice of histopathology. From a single unstained tissue sample, PictorLabs’ proprietary platform can sustainably produce an unlimited number of virtual stains that are indistinguishable from analogous chemical ones. PictorLabs' technology can replicate standard of care stains and perform specialized virtual biomarker stains for indications that require novel and accelerated diagnostic tests. To learn more, visit https://pictorlabs.ai/ and please follow PictorLabs on LinkedIn.
NanoSyrinx
Series A in 2024
NanoSyrinx is a biotechnology company focused on developing an innovative system for the targeted delivery of therapeutic proteins and peptides directly into the cytosol of cells. By employing synthetic biology techniques, the company aims to create a groundbreaking method for drug delivery that enhances the efficacy, safety, and cost-effectiveness of treatments in the biopharmaceutical sector. This novel approach allows for precise delivery of therapeutic agents, potentially improving treatment outcomes for patients by ensuring that the drugs reach their intended cellular targets.
Formo
Series B in 2024
Formo is a pioneering cellular agriculture company based in Europe that specializes in creating animal-free dairy products. By utilizing precision fermentation, Formo develops real, nature-identical milk proteins, allowing for the production of clean dairy alternatives. The company aims to provide sustainable and healthy options for consumers, particularly those seeking vegan food products. Through innovative biotechnology, Formo transforms nutrients into dairy proteins, contributing to a more equitable and environmentally friendly approach to dairy consumption.
Anjuna
Series B in 2024
Anjuna is a developer of a cloud security platform that provides hardware-grade protection for data, applications, and workloads in the public cloud. The company's technology enables enterprises to securely run their most sensitive workloads by leveraging advanced hardware-based secure computing technologies. Unlike traditional perimeter security solutions, which are often vulnerable to insider threats and malicious code, Anjuna's platform offers seamless end-to-end encryption through secure enclaves. This approach ensures that applications and data remain protected from unauthorized access, making the public cloud a safe computing resource for businesses.
Thintronics
Series A in 2024
Thintronics is a Consumer Electronics company.
Hexium
Seed Round in 2024
Hexium provides advance energy to medical industries by using isotope enrichment technology.
Asceneuron
Series C in 2024
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases. Tauopathies are currently untreatable neurodegenerative diseases that rapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
LOST iN
Seed Round in 2024
LOST iN is a mobile app and print guide dedicated to providing travelers with an authentic experience in 17 global cities, focusing on local perspectives. Each month, the platform introduces a new city, curated by a network of opinion leaders from creative backgrounds who provide recommendations that steer clear of tourist traps. The app personalizes suggestions based on user-specific factors such as time, weather, and location, enabling travelers to optimize their itineraries. In addition to digital offerings, LOST iN also provides print guides available in retail and concept stores worldwide, aiming to inspire those seeking to explore cities from a genuine, local viewpoint. The platform emphasizes low-key travel experiences, featuring insights from local chefs, designers, and editors, to help tourists navigate unfamiliar urban environments with ease and confidence.
iOnctura
Series B in 2024
iOnctura is a biopharmaceutical company that develops novel therapeutics aimed at addressing immunosuppression within the tumor microenvironment, which can hinder effective cancer treatment. The company focuses on creating next-generation biomolecules to enhance existing immune checkpoint therapies, ultimately aiming to improve patient outcomes in cancer treatment. Through collaborations with Merck and Cancer Research Technology, iOnctura is advancing a pipeline of preclinical molecules designed to be used in combination with immuno-oncology therapies. With access to state-of-the-art drug discovery laboratories and a network of academic partners, iOnctura is strategically positioned to develop innovative combination therapies in cancer immunology, ensuring a focused approach to tackling the complexities of cancer and fibrosis.
LabGenius
Series B in 2024
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.
Outrun TX
Seed Round in 2024
Outrun TX is a biotechnology company focused on developing a platform for identifying therapeutics that specifically target the protein degradation pathway. The company offers proprietary technology aimed at unlocking the therapeutic potential of protein stabilization through E3 ligase inhibition. This approach is intended to facilitate the treatment of cancer and other diseases, ultimately enabling medical professionals to prevent disease development and progression.
Theolytics
Venture Round in 2024
Theolytics Limited is a clinical-stage biotechnology company founded in 2017 and based in Oxford, United Kingdom. The company specializes in developing oncolytic viral therapies to combat cancer, utilizing a phenotypic screening platform that facilitates the discovery and development of effective, targeted treatment candidates. These therapies are designed for intravenous delivery and tailored to specific patient populations, aiming to provide innovative care options. In addition to advancing its internal pipeline of programs that address both solid and liquid tumors, Theolytics is also focused on forming strategic partnerships to enhance and expedite its pipeline development.
Mosa Meat
Venture Round in 2024
Mosa Meat B.V. is a food technology company based in Maastricht, the Netherlands, founded in 2013. The company specializes in the production of cultured meat by utilizing tissue engineering techniques. Mosa Meat harvests adult stem cells from the muscle tissue of living cows, allowing it to grow meat without the need for animal slaughter. This innovative process enables the production of products such as hamburgers and aims to reduce the environmental impact associated with traditional meat production. By creating real meat from animal cells, Mosa Meat contributes to a more sustainable food system, significantly lowering emissions, water usage, and land requirements while minimizing animal suffering.
Nucleai
Venture Round in 2024
Nucleai Ltd. is a spatial biology company that has developed an AI-powered pathology platform focused on enhancing drug development and improving patient outcomes. Founded in 2017 and headquartered in Tel Aviv-Yafo, Israel, Nucleai's technology utilizes unique tissue datasets and machine learning algorithms to analyze biopsy samples and detect various cancers, including prostate, breast, and gastrointestinal diseases. The platform aims to improve the interpretation of pathology results, thereby increasing the efficacy of clinical trials and fostering better patient care. Nucleai collaborates with leading pharmaceutical companies, licensing its platform for internal use and participating in biomarker discovery projects. By transforming healthcare through artificial intelligence, Nucleai strives to enable researchers to identify novel biomarkers that predict therapeutic responses and enhance understanding of complex biological phenomena.
Celestial AI
Series C in 2024
Celestial AI is a prominent artificial intelligence company that provides an advanced platform for users to efficiently create images, text, and presentations. Utilizing computer vision algorithms and natural language processing, the platform produces high-quality visual and textual content. Its intuitive design and innovative features simplify the creation process, while intelligent data integration and a commitment to security ensure reliable results.
Buzz Solutions
Venture Round in 2024
Buzz Solutions provides a software platform powered by Artificial Intelligence, Actionable Insights, and Predictive Analytics for faults and anomaly detection for the power line inspection process for power utilities. The company's platform automates the process of storing and organizing visual data (captured in the field through drones and helicopters), analyzing for faults using its AI algorithms, mapping the data and providing heat maps as well as predictive insights for when, where and what kind of faults are happening on power line and assets. Using its solutions, power utilities save over 50% of cost and time to analyze data which makes condition-based maintenance efforts easier and time-efficient, thus, preventing wildfires, power outages, and other climate change effects on the physical infrastructure of the grid.
Quintessent
Seed Round in 2024
Quintessent is a Santa Barbara start-up that commercializes quantum dot-based lasers and photonic integrated circuits. Its solutions leverage the unique properties of quantum dot gain media with co-designed architectures to enable future applications in optical networking, deep learning systems, and sensing. It is based in Santa Barbara, California.
Tranquility AI
Pre Seed Round in 2024
Tranquility AI leverage AI to deliver solutions to the most complex problems facing governments and enterprises around the world.
DISCO Pharmaceuticals
Seed Round in 2024
DISCO Pharmaceuticals is a company focused on advancing cancer treatment through its innovative surfaceome mapping platform. This technology enables the identification of proteins and protein communities on the cancer cell surface at a large scale, providing detailed insights that traditional proteomics and genomic methods cannot offer. By unlocking the surfaceome of cancer cells, DISCO Pharmaceuticals aims to facilitate the development of cancer-selective therapies that enhance treatment efficacy while minimizing side effects for patients. The company's approach holds promise for improving patient care by enabling more targeted and effective therapeutic options in oncology.
Polaris Electro-Optics
Seed Round in 2023
Polaris Electro-Optics specializes in integrated photonics, focusing on the development of ferroelectric nematic liquid crystals that enhance the performance of electro-optic modulators. By leveraging patented materials and design innovations, the company produces high-speed, energy-efficient products aimed at improving data transmission in the communications and computation sectors. Their solutions enable faster data movement, addressing the growing demands for efficiency and speed in these industries.
Cambium Carbon
Seed Round in 2023
Cambium Carbon is an early-stage social enterprise focused on addressing climate change through reforestation and urban wood reuse. The company collaborates with cities and various partners to divert fallen city trees from landfills, transforming them into valuable resources. By establishing reforestation hubs, Cambium Carbon creates a circular economy that reclaims urban wood waste and generates revenue. This revenue is then invested in planting and maintaining trees, supporting city planners in creating sustainable jobs and fostering resilient urban environments. Through these initiatives, Cambium Carbon aims to implement effective natural climate solutions while promoting local regenerative wood supply chains.
Nouscom
Series C in 2023
Nouscom is a biotechnology company focused on developing an immunotherapy platform that creates modified viral vector vaccines for cancer treatment. The company utilizes a range of engineered viral vectors optimized for the effective expression of long strings of tumor neoantigens. Additionally, its platform includes tools designed to induce broad and potent antitumor T-cell responses, which aim to enhance cancer-specific cellular immunity in patients.
Shekel Mobility
Seed Round in 2023
Shekel Mobility is a financial technology company focused on providing a comprehensive platform for auto dealerships. The platform offers a range of services including credit financing, dealership management, and operational tools aimed at enhancing the efficiency and market potential of auto dealers. By facilitating access to low-interest financing, Shekel Mobility supports used-car dealership transactions and operations, allowing dealers to discover, finance, and exchange vehicles more effectively. The company's solutions are designed to empower dealerships, equipping them with the necessary resources for sustainable growth in a competitive automotive market.
Swsh
Pre Seed Round in 2023
Swsh is a social app that aims to strengthen true friendships rather than superficial relationships with followers.
Stoke Space
Series B in 2023
Stoke Space is dedicated to developing a fully reusable medium-lift rocket named Nova, aimed at providing cost-effective and sustainable access to space. The company focuses on creating rockets that can be reused multiple times, offering low-cost, on-demand launch services designed for daily operations. By emphasizing sustainability, Stoke Space seeks to reduce the atmospheric impact of space missions while supporting the growth of the space economy. Their vertically integrated design and manufacturing capabilities enable them to deliver reliable solutions for clients looking to launch satellites efficiently and sustainably.
CellFE
Series A in 2023
CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
Chef Robotics
Funding Round in 2023
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.
Theolytics
Series A in 2023
Theolytics Limited is a clinical-stage biotechnology company founded in 2017 and based in Oxford, United Kingdom. The company specializes in developing oncolytic viral therapies to combat cancer, utilizing a phenotypic screening platform that facilitates the discovery and development of effective, targeted treatment candidates. These therapies are designed for intravenous delivery and tailored to specific patient populations, aiming to provide innovative care options. In addition to advancing its internal pipeline of programs that address both solid and liquid tumors, Theolytics is also focused on forming strategic partnerships to enhance and expedite its pipeline development.
Crate
Seed Round in 2023
Crate is an AI-driven platform that transforms content consumption and sharing. Founded in 2021 and based in Los Angeles, California, the company offers a solution that allows users to collect and save content from various apps and websites. Its platform enables individuals to organize, group, label, and annotate articles, podcasts, videos, and tweets. By streamlining the process of importing content from other platforms, Crate empowers content creators to customize, curate, and share their work effortlessly. The company aims to enhance how users interact with digital content, making it more accessible and engaging.
Lightcast Discovery
Series B in 2023
Lightcast Discovery Limited, founded in 2019 and based in Cambridge, United Kingdom, specializes in advancing drug discovery through its innovative microfluidic platform. This technology allows for precise control of thousands of droplets, enabling complex cell analysis and workflows without manual manipulation. By leveraging this platform, Lightcast collaborates with major pharmaceutical companies and leading academic institutions to develop new therapies and products. The company's focus is on pushing the boundaries of complex cell analysis, thereby facilitating the discovery of unique clinical approaches in the field of drug development.
NeoLogic (VLSI)
Seed Round in 2023
Powering the next generation processors with a new paradigm of VLSI design
Exponential Markets
Seed Round in 2023
Exponential Markets is focused on creating innovative financial instruments aimed at enhancing hedging capabilities and risk management across various asset classes. The company's initial offering, the Exponential Used Vehicle Index, represents a novel tradable index for the automotive sector, enabling rental car companies, auto insurers, and lessors to mitigate risks associated with used vehicle prices. Additionally, Exponential Markets is developing a financial platform that seeks to establish a modern exchange for the evolving economy, featuring tradable and brokered financial products. The company plans to expand its offerings to include cash-settled index derivatives for new and underserved markets, while also exploring applications for smart market technologies.
Gradia Health
Seed Round in 2023
Gradia Health is an integrated concierge care platform that supports clinics in managing patients with chronic conditions. The company has developed a health information application that delivers timely, customized content directly to patients' phones. This application provides essential information related to upcoming appointments and procedures, enhances patient understanding of their diagnoses through electronic health records, and offers post-visit resources to help patients effectively manage their conditions. By focusing on patient education, Gradia Health aims to improve health outcomes for both patients and healthcare providers.
Celestial AI
Series B in 2023
Celestial AI is a prominent artificial intelligence company that provides an advanced platform for users to efficiently create images, text, and presentations. Utilizing computer vision algorithms and natural language processing, the platform produces high-quality visual and textual content. Its intuitive design and innovative features simplify the creation process, while intelligent data integration and a commitment to security ensure reliable results.
Astraveus
Seed Round in 2023
Astraveus is transforming cell and gene therapy (CGT) manufacturing through its Lakhesys™ platform, an innovative cell foundry that leverages deep process optimization and microfluidic bioprocessors. This technology allows for the production of personalized biological therapies with minimal infrastructure requirements, ultimately reducing costs and addressing logistical challenges in the industry. By automating autologous bioproduction, the platform enhances the efficiency of transforming cells into therapeutic agents, enabling healthcare providers to scale the development and manufacturing of CGT solutions. Astraveus aims to improve patient access to these vital therapies while minimizing environmental impact.
PredictionStrike
Series A in 2023
PredictionStrike is a simulated stock market platform that enables users to buy and sell shares of professional athletes, creating an engaging fantasy contest. This innovative platform allows fans to analyze their favorite athletes' performances while potentially earning monetary returns. By combining elements of sports fandom and investment, PredictionStrike provides users with a unique opportunity to monetize and trade virtual shares based on athlete performance, enhancing the overall experience for sports enthusiasts.
Haiqu
Pre Seed Round in 2023
Haiqu Inc. is a quantum computing software company that specializes in developing technology to enhance the performance of contemporary quantum hardware. The firm focuses on creating software solutions that address barriers to the adoption of scalable quantum applications, facilitating a wider range of practical use cases across various sectors, including finance, life sciences, and mobility. By leveraging advancements in circuit compression and quantum distributed computing, Haiqu's platform aims to optimize the functionality of quantum computers, allowing users to operate without cumbersome quantum hardware.
NUVIEW
Series A in 2023
NUVIEW is developing the world's first commercial LiDAR satellite constellation, aimed at delivering a continuously updated global 3D point cloud from space. This innovative technology provides high-resolution representations of the Earth's surface and precise measurements, allowing for applications across various industries, including environmental science, infrastructure planning, agriculture, forestry, and archaeology. By harnessing advanced satellite, sensor, and software technology, NUVIEW offers valuable data processing services that enable organizations to make informed decisions in climate research, renewable energy, and environmental management. The company is led by a team with proven experience in achieving commercial success on a global scale, combining technical expertise with operational knowledge to address complex scientific and commercial challenges.
Cookbook.dev
Seed Round in 2023
Cookbook operates a free smart contract marketplace designed to assist developers in finding, customizing, and deploying smart contracts. The platform offers a collection of open-source smart contract templates and provides comprehensive documentation on their usage. By streamlining the process of exploring various smart contracts, Cookbook enables users to access essential resources such as documentation, audits, and source code, thereby simplifying the development of web3 applications for companies.
Anavo Therapeutics
Seed Round in 2023
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications
Love.com
Venture Round in 2023
Love.com is an online marketplace focused on providing sustainable and quality products. The platform features a diverse selection of items, including fitness supplements, food and beverages, wearables, and personal care products. Emphasizing small businesses and eco-friendly ingredients, Love.com aims to offer customers a variety of choices while promoting sustainability. This approach aligns with the growing consumer demand for products that are both environmentally conscious and health-oriented.
Ox
Series A in 2023
Ox is an enterprise software provider focused on enhancing supply chain operations through human-centered automation. The company specializes in developing augmented reality software that aims to optimize warehouse efficiency. By utilizing machine learning and a range of customized tools, Ox’s solutions enhance the capabilities of industrial warehouse operators. Their software incorporates artificial intelligence algorithms that monitor and improve workforce performance, facilitating better inventory management. Through integration with cloud-based application program interfaces, Ox enables clients to streamline operations and achieve greater operational excellence.
Mansa
Seed Round in 2023
Mansa develops a streaming platform featuring black culture. They are removing obstacles and integrating all formats. With tales from all over the world, they're displaying both fresh talent and seasoned pros. With their "Watch Out Loud Feature," they're linking viewers with one another, and with Web3 features, they'll be connecting creators with their audiences.
Flyby Robotics
Pre Seed Round in 2023
Flyby Robotics is a developer of American-made autonomous drones designed to facilitate machine learning capabilities at the edge. The company focuses on eliminating critical Chinese electronic components from its products, ensuring a secure operating environment. Its platform streamlines the processing of machine learning applications on drones, enhancing the operational experience for users. This technology enables drone operators to execute complex autonomous missions across various sectors, including delivery, critical infrastructure, renewable energy, and public safety.
PxE
Seed Round in 2023
PxE develops a 3D imaging technology designed to augment standard CMOS camera architecture. By augmenting standard CMOS camera architecture with a simple, passive optical element, PxE’s proprietary algorithm is able to retrieve a high-resolution (spatial and depth) 3D image of any scene in real-time (in addition to the optical image).
Iktos
Series A in 2023
Iktos is a French company focused on artificial intelligence and robotic solutions for medicinal chemistry and drug design. It offers a proprietary generative AI technology that optimizes molecule design for small molecule discovery projects, significantly enhancing productivity in pharmaceutical research and development. Iktos provides its innovative solutions through its SaaS platforms, Makya™ for generative drug design and Spaya™ for retrosynthesis, while also engaging in strategic partnerships with pharmaceutical companies to accelerate drug discovery. Additionally, Iktos has developed an AI-driven synthesis automation platform, Iktos Robotics, which expedites the Design-Make-Test-Analyze cycle in drug development. The company is also advancing its own pipeline of drug candidates aimed at oncology and autoimmune diseases. In March 2023, Iktos secured a significant financing round, and in July 2024, it enhanced its capabilities by acquiring Synsight, which adds a biology platform for discovering drugs targeting Protein-Protein and RNA-Protein interactions.
Starfish Space
Series A in 2023
Starfish Space Inc. specializes in providing on-demand in-space transportation and maintenance services for satellites. The company develops small space tugs equipped with proprietary Proximity Operations Software, which integrates orbital mechanics, machine vision artificial intelligence, and a low-thrust electric propulsion system. This innovative technology allows the tugs to conduct various satellite servicing missions, including life extension, relocation, disposal, and inspection. Founded in 2019 and based in Kent, Washington, Starfish Space aims to support satellite companies by enhancing their operational capabilities in orbit.
Archetype
Seed Round in 2023
Archetype provides APIs through developer-led integrations, allowing it to launch and automate complex metering and billing models with custom permissions. They offer services that include APIs, analytics, and API management.
Haxion
Pre Seed Round in 2023
Haxion is a company focused on developing artificial intelligence systems specifically designed for national security applications. Currently operating in stealth mode, Haxion is engaged in the creation of advanced AI technologies that aim to enhance security measures and improve national defense capabilities. The company's work is geared towards addressing complex challenges within the national security sector, leveraging innovative AI solutions to provide critical support and insights.
Spartan Radar
Series B in 2023
Spartan Radar specializes in advanced radar technology that creates high-resolution real-time imagery, utilizing proprietary software algorithms that incorporate machine learning and edge-processing. By mimicking human sensory perception, Spartan's solutions enhance the performance of existing advanced driver-assistance systems (ADAS) by improving resolution, response time, and range while maintaining low computational demands. The company's expertise in signal processing, developed through years of experience in the aerospace and automotive sectors, enables it to offer cost-effective sensing solutions. Spartan's platform is applicable across various industries, including drone and automotive applications, positioning the company as a leader in innovative radar technology.
Chef Robotics
Seed Round in 2023
Chef Robotics is a robotics and artificial intelligence company serving the food industry. The company was founded in 2019 and is headquartered in San Francisco, California.
MetaTrust Labs
Seed Round in 2023
MetaTrust offers a builder-first web3 security platform for web3 application security scanning. MetaTrust employs a developer-centric approach, combining multiple security scanning engines into a single platform with unprecedented speed and accuracy, securing applications beyond the smart contract layer. MetaTrust evaluates the health of project source code and development events, reviews process quality for contract deployment, and analyzes transaction and token holder distribution using on-chain data from web3 projects.
Blaze.tech
Pre Seed Round in 2023
Blaze is the AI-powered no-code platform that empowers teams to build secure, scalable applications and internal tools—fast. With its powerful no-code builder, organizations can create HIPAA-compliant apps in days, not months, all without writing code or hiring engineers. From patient portals to telehealth solutions to real-time dashboards, Blaze is setting a new standard for speed and innovation in healthcare. Trusted by Fortune 500 companies and loved by startups, Blaze helps teams move faster without compromising security or compliance.
ImmuneBridge
Venture Round in 2023
ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural killer cell-based treatments for hematological cancers. They will then attack solid tumors using the special benefits of their cellular source.
Farcast
Venture Round in 2022
We build advanced satcom terminals
STORM Therapeutics
Series B in 2022
Targeting pathways that modify RNA to deliver novel cancer therapeutics.
Sonde
Series B in 2022
Sonde Health is a digital medicine company developing voice-based technologies to transform the way we monitor and diagnose our mental and physical health.
Buzz Solutions
Venture Round in 2022
Buzz Solutions provides a software platform powered by Artificial Intelligence, Actionable Insights, and Predictive Analytics for faults and anomaly detection for the power line inspection process for power utilities. The company's platform automates the process of storing and organizing visual data (captured in the field through drones and helicopters), analyzing for faults using its AI algorithms, mapping the data and providing heat maps as well as predictive insights for when, where and what kind of faults are happening on power line and assets. Using its solutions, power utilities save over 50% of cost and time to analyze data which makes condition-based maintenance efforts easier and time-efficient, thus, preventing wildfires, power outages, and other climate change effects on the physical infrastructure of the grid.
WARP
Seed Round in 2022
Warp connects shippers, carriers, and facilities to find the most efficient route for middle-mile freight. The first freight network of its kind, Warp weaves together digital pooling, back-hauls, and physical consolidation points (Warp Stations), to provide shippers with a cost structure for shippers previously unthinkable with old school trucking companies.
Tactyc
Seed Round in 2022
Tactyc is a performance forecasting and scenario planning platform tailored for venture capital firms. It allows funds to construct, manage, and forecast venture portfolios efficiently, replacing traditional spreadsheet workflows for over 250 funds globally. The platform simplifies portfolio modeling, enabling managers to build and maintain their models without the complexities of spreadsheets. Users can quickly construct portfolios and share their fund strategies with potential investors. Additionally, Tactyc provides analytics to help general partners optimize reserves, analyze investment outcomes, and derive insights for future capital deployment. This combination of features empowers venture capitalists to make data-driven decisions and enhances their overall investment strategies.
Wyvern
Seed Round in 2022
Wyvern operates hyperspectral Earth observation satellites designed to capture high-resolution imagery across various spectral bands. By utilizing advanced hyperspectral sensors, the satellites can identify distinct chemical and physical properties of the Earth's surface. This capability makes Wyvern's imagery a valuable resource for applications in site monitoring, mapping, and geospatial intelligence. The company's smaller satellites maintain the same spatial resolution and superior spectral content as larger counterparts, allowing industries such as agriculture, forestry management, and environmental monitoring to access critical data at a more affordable price. This enables faster, informed decision-making across multiple sectors.
Fursure
Seed Round in 2022
Fursure is the first financial platform for pet parents, spanning debit cards, insurance, and more — disrupting how Americans spend money on their cumulative 185 million pets, a >$120B market, growing to $275B by the end of the decade. Fursure simplifies getting insurance with a national pet insurance marketplace, rewards pet parents for everyday spend that they can redeem on veterinary care and save in a rainy day fund for emergencies, and offers exclusive discounts on best-in-class products across pet categories. Fursure's cofounders were Princeton classmates, former Facebook Senior PM (CEO) and Amazon Architect (CTO), and featured as Forbes 30 Under 30 in Consumer Technology 2022.
DwellWell
Seed Round in 2022
DwellWell is an online platform for home buyers that gives them the most transparent, enjoyable experience through a guided process that includes education, access to resources, and connections to the best real estate experts. DwellWell Super Agents gain high-intent home buyer leads that are looking to make a purchase in their region quickly. DwellWell creates delighted home buyers and successful real estate agents automatically.
Nucleome Therapeutics
Series A in 2022
Nucleome Therapeutics is a biotechnology company based in Oxford, United Kingdom, focused on transforming drug discovery by decoding the complexities of the human genome. Founded in 2019, the company utilizes a unique genomics platform that leverages the three-dimensional structure of the genome and machine learning to explore the vast, largely uncharted regions of the genome, often referred to as the dark matter. This area contains over 95% of disease-linked genetic variants, providing significant opportunities for identifying new therapeutic targets. Nucleome Therapeutics specializes in creating high-resolution genome structure maps and validating genetic variants in primary cell types, facilitating the discovery and development of novel precision medicines. The company's initial emphasis is on lymphocytes and autoimmune diseases, with the goal of establishing a robust pipeline of drug candidates and corresponding biomarkers. Founded by experts in gene regulation from the University of Oxford, Nucleome is backed by investments from Oxford Sciences Innovation.
Stears
Seed Round in 2022
Stears is a data and intelligence company headquartered in Lagos, Abuja, and London. Founded in 2017 by a group of individuals who met at prominent institutions in the UK, Stears initially began as a media publication known as Stears Business. It has since transformed into a provider of subscription-based data collection tools and insight services designed for businesses and professionals engaged in Africa. The company aims to become the most trusted source of African data and insights, offering comprehensive coverage of finance, economics, and development. By centralizing data from various local and international sources, Stears enables its audience to access in-depth business news analysis and insights from experts across sectors such as banking, consulting, law, academia, government, and civil society.
Metalenz
Series B in 2022
Metalenz, Inc. is a company focused on the research, development, and production of advanced optical components, particularly for consumer electronics such as mobile phones and computers. Established in 2016 and headquartered in Weston, Massachusetts, with an additional office in San Francisco, Metalenz specializes in meta-optics that utilize structured Huygens' surfaces to manipulate light properties. This innovative approach allows for the creation of ultra-thin planar optics that enable high-resolution full-color imaging. By offering smaller and lighter alternatives to traditional lenses, Metalenz supports businesses in miniaturizing their products, enhancing their design flexibility and functionality in various high-volume applications, including automotive and other electronic devices.
Spleet
Seed Round in 2022
Spleet is a fintech company that specializes in providing solutions for the rental market. It offers tenant verification and rent collection services for landlords, along with a rent financing option that allows tenants to pay later. Spleet operates a rental home listing platform that focuses on affordable living spaces, featuring fully furnished accommodations with flexible payment and sharing options. In addition to these services, Spleet also provides cleaning and security services, along with other amenities, to facilitate a smooth transition for tenants moving into their new homes while helping homeowners maximize their rental income.
PredictionStrike
Seed Round in 2022
PredictionStrike is a simulated stock market platform that enables users to buy and sell shares of professional athletes, creating an engaging fantasy contest. This innovative platform allows fans to analyze their favorite athletes' performances while potentially earning monetary returns. By combining elements of sports fandom and investment, PredictionStrike provides users with a unique opportunity to monetize and trade virtual shares based on athlete performance, enhancing the overall experience for sports enthusiasts.
MEDU Protection
Seed Round in 2022
We produce sustainable medical equipment, innovating and saving costs while protecting healthcare professionals.
Love.com
Seed Round in 2022
Love.com is an online marketplace focused on providing sustainable and quality products. The platform features a diverse selection of items, including fitness supplements, food and beverages, wearables, and personal care products. Emphasizing small businesses and eco-friendly ingredients, Love.com aims to offer customers a variety of choices while promoting sustainability. This approach aligns with the growing consumer demand for products that are both environmentally conscious and health-oriented.
Galvanick
Seed Round in 2022
Galvanick is a developer of a cybersecurity platform focused on securing industrial operations environments. The platform aggregates telemetry from various industrial settings, allowing for the contextualization of data to highlight critical malicious behavior. This enables operations and security teams to swiftly identify and respond to threats, thereby minimizing cyber risks to industrial infrastructure. By acting as an intelligence augmentation tool, Galvanick enhances human oversight in the cyber-physical realm, where actions can have significant real-world consequences. The cloud-native analysis platform facilitates quicker detection of anomalous behavior, helping industrial companies protect their most sensitive assets.
AMP Global Clearing
Seed Round in 2022
AMP Global Clearing provides trading platforms. They offers self directed trading, autotrading strategies, introducing brokers, foreign introducing broker, referral partner program, ira traditional, roth, cqg data, amp exchanges, trading technologies, and rithmic data services.
Xona Space Systems
Venture Round in 2022
Xona Space Systems, Inc. specializes in developing and manufacturing position, navigation, and timing (PNT) satellite solutions. Founded in 2019 and headquartered in San Mateo, California, the company is focused on creating a constellation of low-cost, low-Earth orbiting satellites designed to enhance navigation for various applications, including autonomous vehicles, unmanned aerial vehicles, and mobile robotics. Their flagship product, the Xona Pulsar, delivers high-power signals from low Earth orbit, ensuring secure and accurate navigation and timing services. This innovative approach aims to meet the demands of smart transportation and smart infrastructure, providing the resilience and precision necessary for modern intelligent systems to operate safely and efficiently at scale.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.